Delayed disease progression in cynomolgus macaques infected with ebola virus makona strain

Emerging Infectious Diseases

Volumn 21, Issue 10, 2015, Pages 1777-1783

  Marzi, Andrea ^a   Feldmann, Friederike ^a   Hanley, Patrick W ^a   Scott, Dana P ^a   Günther, Stephan ^b   Feldmann, Heinz ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 23P40; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; DISEASE COURSE; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; MACACA FASCICULARIS; MALE; NEUTROPHIL COUNT; NONHUMAN; SCORING SYSTEM; SURVIVAL RATE; THROMBOCYTE COUNT; VIRUS LOAD; ANIMAL; DISEASE MODEL; MORTALITY; PATHOGENICITY; PATHOLOGY; VIROLOGY; VIRULENCE;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; MACACA FASCICULARIS; VIRULENCE;

EID: 84942097404     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2110.150259     Document Type: Article

References (13)

1. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet. 2011;377:849-62. http://dx.doi.org/10.1016/S0140-6736(10)60667-8
2. Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med. 2014;371:1418-25. http://dx.doi.org/ 10.1056/NEJMoa1404505
3. World Health Organization. Ebola situation report, May 13, 2015. Geneva: The Organization; 2015.
4. Brining DL, Mattoon JS, Kercher L, LaCasse RA, Safronetz D, Feldmann H, et al. Thoracic radiography as a refinement methodology for the study of H1N1 influenza in cynomologus macaques (Macaca fascicularis). Comp Med. 2010;60:389-95.
5. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. American Journal of Hygiene. 1938;27:493-7.
6. Groseth A, Marzi A, Hoenen T, Herwig A, Gardner D, Becker S, et al. The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo. PLoS Pathog. 2012;8:e1002847. http://dx.doi.org/10.1371/journal.ppat.1002847
7. Ebihara H, Rockx B, Marzi A, Feldmann F, Haddock E, Brining D, et al. Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus. J Infect Dis. 2011;204(Suppl 3): S991-9. http://dx.doi.org/10.1093/infdis/jir336
8. Geisbert TW, Hensley LE, Larsen T, Young HA, Reed DS, Geisbert JB, et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol. 2003;163:2347-70. http://dx.doi.org/10.1016/S0002-9440(10)63591-2
9. Martins K, Cooper C, Warren T, Wells J, Bell T, Raymond J, et al. Characterization of clinical and immunological parameters during Ebola virus infection of rhesus macaques. Viral Immunol. 2015;28:32-41. http://dx.doi.org/10.1089/vim.2014.0085
10. Villinger F, Rollin PE, Brar SS, Chikkala NF, Winter J, Sundstrom JB, et al. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factoralpha associated with fatal Ebola virus infection. J Infect Dis. 1999;179(Suppl 1):S188-91. http://dx.doi.org/10.1086/514283
11. Kurtulus S, Tripathi P, Hildeman DA. Protecting and rescuing the effectors: roles of differentiation and survival in the control of memory T cell development. Front Immunol. 2012;3:404.
12. Bah EI, Lamah MC, Fletcher T, Jacob ST, Brett-Major DM, Sall AA, et al. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med. 2015;372:40-7. http://dx.doi.org/10.1056/NEJMoa1411249
13. Schieffelin JS, Shaffer JG, Goba A, Gbakie M, Gire SK, Colubri A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med. 2014;371:2092-100. http://dx.doi.org/10.1056/NEJMoa1411680